Message-ID: <17550633.1075852807350.JavaMail.evans@thyme>
Date: Tue, 16 Oct 2001 16:00:04 -0700 (PDT)
From: brown_mary_jo@lilly.com
Subject: Press Release
Cc: decoudreaux_alecia_a@lilly.com
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
Bcc: decoudreaux_alecia_a@lilly.com
X-From: BROWN_MARY_JO@LILLY.COM@ENRON
X-To: alfred.gilman@utsouthwestern.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com, karen.n.horn@marsh.com, Lay, Kenneth </O=ENRON/OU=NA/CN=RECIPIENTS/CN=KLAY>, kseifert@kcc.com, prendergast@mayo.edu, scb@purdue.edu, win.bischoff@ssmb.com
X-cc: DECOUDREAUX_ALECIA_A@LILLY.COM
X-bcc: 
X-Folder: \KLAY (Non-Privileged)\Inbox
X-Origin: Lay-K
X-FileName: KLAY (Non-Privileged).pst


The attached press release was issued today over Business Wire at approximately 5:56 pm (EST) Indy time. 
We will keep you advised of developments. 
Alecia DeCoudreaux 

 - FDA Adv Comm -- split FINAL.doc 